Kidney and Pancreas Transplant Center

Innovative research at Cedars-Sinai has made it possible for people who are highly sensitized (have high antibodies to transplant targets) to successfully receive kidney transplants. Other research being done at Cedars-Sinai is helping to break down barriers of blood and tissue incompatibility.

In 1999, Cedars-Sinai received United Network for Organ Sharing certification for pancreas transplantation. Cedars-Sinai is one of a select few medical centers in Southern California performing kidney-pancreas transplants. Pancreas transplantation is used to prevent or reverse secondary complications of diabetes. The treatment is reserved for patients who are undergoing kidney transplantation and are also Type 1 Diabetic. Diabetic patients who have already undergone kidney transplantation are also candidates.

Patient Story

successful kidney transplants

Dylan Worthen, 11

Kidney Recipient

Ten years ago, Dylan became the youngest, smallest kidney transplant recipient ever at Cedars-Sinai. Today, he’s a healthy tween.

Read Full Story

Featured Treatment

immunotherapy treatment for patients awaiting kidney transplants

HLA-Sensitized Transplantation

One third of patients awaiting kidney transplants are highly HLA-sensitized. The only option? Dialysis for life. That is, until recently...

Learn More